77. Growth hormone secreting pituitary adenoma Disease details / Clinical trials / Drug dev / DR info
Clinical trial : 1 / Drug : 1 - (DrugBank : 1) / Drug target genes : 2 - Drug target pathways : 20
Growth hormone secreting pituitary adenoma and other diseases between which drug repositioning might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Drug repositionability
ID | Diseases (Sorted by drug repositionability) |
---|---|
77 | Growth hormone secreting pituitary adenoma |
81 | Congenital adrenal hyperplasia |
206 | Fragile X syndrome |
225 | Congenital nephrogenic diabetes insipidus |
233 | Wolfram syndrome |
301 | Macular dystrophy |
13 | Multiple sclerosis/Neuromyelitis optica |
6 | Parkinson disease |
299 | Cystic fibrosis |
2 | Amyotrophic lateral sclerosis |
75 | Cushing disease |
46 | Malignant rheumatoid arthritis |
49 | Systemic lupus erythematosus |
60 | Aplastic anemia |
65 | Primary immunodeficiency |
67 | Polycystic kidney disease |
86 | Pulmonary arterial hypertension |
127 | Frontotemporal lobar degeneration |
158 | Tuberous sclerosis |
285 | Fanconi anemia |
8 | Huntington disease |
113 | Muscular dystrophy |
265 | Lipodystrophy |
97 | Ulcerative colitis |